Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases
Clinical trial NCT07638709 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07638709
- Sponsor
- Xiangya Hospital of Central South University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-05
- Primary completion
- 2029-05-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.